{"error":false,"id":["167432"],"data":{"IVOD_ID":167432,"IVOD_URL":"https://ivod.ly.gov.tw/Play/Clip/1M/167432","日期":"2026-03-03","會議資料":{"會議代碼":"院會-11-5-1","會議代碼:str":"第11屆第5會期第1次會議","屆":11,"會期":5,"會次":1,"臨時會會次":null,"種類":"院會","標題":"第11屆第5會期第1次會議"},"影片種類":"Clip","開始時間":"2026-03-03T16:34:51+08:00","結束時間":"2026-03-03T16:50:23+08:00","影片長度":"00:15:32","支援功能":["ai-transcript","gazette"],"video_url":"https://h264media01.ly.gov.tw:443/vod_1/_definst_/mp4:1MClips/321e35c043cc325ba1ed92dda1aef04d05351cf5c593b4e3b151ec866a2b73e87ddab3ead9da41ef5ea18f28b6918d91.mp4/playlist.m3u8","委員名稱":"許宇甄","委員發言時間":"16:34:51 - 16:50:23","會議時間":"2026-03-03T09:00:00+08:00","會議名稱":"第11屆第5會期第1次會議（事由：一、行政院院長提出施政方針及施政報告並備質詢（2月24日下午）。二、行政院院長提出臺美關稅談判結果及其影響專案報告並備質詢（3月3日）。）","transcript":{"pyannote":[{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":4.31721875,"end":7.709093750000001,"speaker_score":0.909},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":8.265968750000003,"end":9.46409375,"speaker_score":0.861},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":19.09971875,"end":19.77471875,"speaker_score":0.861},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":19.77471875,"end":30.91221875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":31.01346875,"end":83.07284375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":83.54534375,"end":127.15034375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":127.58909375,"end":188.22096875000003,"speaker_score":0.909},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":189.09846875000002,"end":194.29596875000001,"speaker_score":0.861},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":194.85284375,"end":196.06784375,"speaker_score":0.861},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":196.60784375,"end":199.08846875,"speaker_score":0.861},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":199.62846875000002,"end":208.21784375000001,"speaker_score":0.861},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":205.63596875000002,"end":206.04096875000002,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":207.47534375,"end":209.09534375,"speaker_score":0.909},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":209.61846875,"end":214.95096875000002,"speaker_score":0.861},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":211.54221875000002,"end":212.21721875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":215.32221875000002,"end":215.59221875,"speaker_score":0.909},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":215.74409375000002,"end":216.50346875000002,"speaker_score":0.861},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":216.89159375000003,"end":221.61659375000002,"speaker_score":0.861},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":221.21159375000002,"end":237.44534375,"speaker_score":0.909},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":226.74659375000002,"end":226.78034375000001,"speaker_score":0.861},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":226.79721875,"end":226.81409375,"speaker_score":0.861},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":236.39909375000002,"end":264.76596875,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":238.45784375000002,"end":238.79534375000003,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":252.53159375,"end":255.38346875000002,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":255.55221875,"end":255.72096875000003,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":256.83471875000004,"end":259.06221875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":260.73284375000003,"end":261.30659375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":265.08659375,"end":272.81534375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":274.68846875,"end":275.05971875,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":275.39721875000004,"end":293.65596875,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":278.33346875,"end":278.82284375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":284.54346875000005,"end":287.34471875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":287.95221875000004,"end":290.41596875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":293.65596875,"end":293.67284375,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":293.67284375,"end":293.68971875,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":293.68971875,"end":300.69284375,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":293.90909375,"end":298.80284375,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":301.04721875,"end":302.29596875000004,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":301.21596875,"end":305.51909375,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":302.44784375,"end":302.86971875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":303.98346875000004,"end":307.45971875000004,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":306.24471875,"end":310.02471875000003,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":310.58159375,"end":339.69096875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":340.23096875000005,"end":346.67721875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":347.16659375,"end":347.75721875000005,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":348.14534375,"end":350.50784375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":350.86221875,"end":382.18221875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":382.53659375,"end":410.49846875000003,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":410.73471875,"end":424.96034375000005,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":425.12909375000004,"end":453.96846875000006,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":439.25346875,"end":442.52721875000003,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":450.91409375,"end":454.03596875000005,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":453.96846875000006,"end":455.01471875000004,"speaker_score":0.868},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":454.03596875000005,"end":457.12409375000004,"speaker_score":0.989},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":455.74034375,"end":462.32159375000003,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":458.45721875000004,"end":458.52471875000003,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":462.42284375,"end":465.42659375000005,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":465.57846875,"end":470.28659375,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":470.30346875000004,"end":473.44221875000005,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":473.74596875000003,"end":480.29346875000005,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":477.07034375,"end":491.58284375000005,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":483.17909375000005,"end":485.22096875000005,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":486.55409375000005,"end":488.79846875000004,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":489.50721875000005,"end":493.16909375000006,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":493.16909375000006,"end":509.80784375,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":493.28721875,"end":493.67534375,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":501.25221875000005,"end":501.28596875000005,"speaker_score":0.868},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":501.28596875000005,"end":501.72471875,"speaker_score":0.989},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":501.72471875,"end":501.75846875,"speaker_score":0.868},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":506.23034375000003,"end":507.52971875000003,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":508.54221875,"end":519.8315937500001,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":519.5278437500001,"end":519.78096875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":519.8315937500001,"end":543.25409375,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":519.8484687499999,"end":519.86534375,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":544.23284375,"end":562.1709687499999,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":546.74721875,"end":550.67909375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":560.9053437499999,"end":570.0347187500001,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":563.04846875,"end":563.3859687500001,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":563.74034375,"end":564.6684687500001,"speaker_score":0.989},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":566.30534375,"end":567.97596875,"speaker_score":0.861},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":567.97596875,"end":568.97159375,"speaker_score":0.989},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":568.97159375,"end":569.0390937500001,"speaker_score":0.861},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":569.0390937500001,"end":599.8190937500001,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":574.2197187500001,"end":577.71284375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":598.78971875,"end":650.66346875,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":642.39471875,"end":643.35659375,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":650.8659687500001,"end":666.4753437500001,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":666.6609687499999,"end":687.51846875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":687.9909687500001,"end":711.0928437500002,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":711.3290937500001,"end":733.18221875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":733.5703437500001,"end":734.2790937500001,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":735.30846875,"end":743.9822187500001,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":744.01596875,"end":748.4709687500001,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":748.6397187500002,"end":759.77721875,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":760.1484687500001,"end":764.18159375,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":764.2490937500002,"end":765.66659375,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":765.83534375,"end":774.71159375,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":773.7665937500001,"end":780.9890937499999,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":777.7322187500001,"end":779.18346875,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":779.90909375,"end":791.58659375,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":788.2622187500001,"end":789.61221875,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":791.2153437500001,"end":798.03284375,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":793.3078437500001,"end":793.81409375,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":798.15096875,"end":803.6184687500001,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":803.7703437500002,"end":807.8372187500001,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":807.9384687500001,"end":828.28971875,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":818.97471875,"end":819.29534375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":821.1684687500001,"end":823.4128437500001,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":825.64034375,"end":825.87659375,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":827.00721875,"end":831.8672187500001,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":831.81659375,"end":842.88659375,"speaker_score":0.989},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":833.23409375,"end":834.43221875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":838.80284375,"end":841.18221875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":841.9922187500001,"end":869.32971875,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":843.1228437500001,"end":844.5065937500001,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":846.3290937500001,"end":848.55659375,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":850.6997187500001,"end":850.9697187500001,"speaker_score":0.989},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":850.9697187500001,"end":853.83846875,"speaker_score":0.868},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":854.1928437500001,"end":854.26034375,"speaker_score":0.861},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":854.26034375,"end":854.32784375,"speaker_score":0.868},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":854.32784375,"end":854.96909375,"speaker_score":0.989},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":854.96909375,"end":856.3190937500001,"speaker_score":0.868},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":868.62096875,"end":868.63784375,"speaker_score":0.989},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":868.63784375,"end":869.1440937500001,"speaker_score":0.868},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":869.1440937500001,"end":871.9284687500001,"speaker_score":0.989},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":869.32971875,"end":869.44784375,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":869.44784375,"end":869.46471875,"speaker_score":0.909},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":869.46471875,"end":869.5322187500001,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":870.17346875,"end":876.77159375,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":871.9284687500001,"end":871.97909375,"speaker_score":0.909},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":871.97909375,"end":872.0803437500001,"speaker_score":0.989},{"speaker":"SPEAKER_03","speaker_name":"鄭副院長麗君","start":872.13096875,"end":872.2322187500001,"speaker_score":0.989},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":877.04159375,"end":877.5984687500002,"speaker_score":0.868},{"speaker":"SPEAKER_00","speaker_name":"石部長崇良","start":877.8347187500001,"end":884.82096875,"speaker_score":0.868},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":885.07409375,"end":887.65596875,"speaker_score":0.909},{"speaker":"SPEAKER_02","speaker_name":"許委員宇甄","start":888.2803437500002,"end":923.3972187500001,"speaker_score":0.909},{"speaker":"SPEAKER_01","speaker_name":"卓院長榮泰","start":927.0590937500001,"end":931.51409375,"speaker_score":0.861}],"whisperx":[{"start":4.814,"end":8.909,"text":"謝謝院長 我們請卓榮泰卓院長麻煩再請卓院長備詢"},{"start":19.193,"end":47.188,"text":"徐委員好主委長好主委長這段時間以來因為行政院一直以這個我們這次談判的一個重大突破跟強調它的成果跟紅利那但是呢當然針對這個部分的話政策的評價我想不是只有我們自己的大內宣應該還要回歸到我們這個雙方的這個條文本身是不是權利義務能夠對等還有風險是不是可以控管"},{"start":47.947,"end":73.457,"text":"因為其實我們看到這49頁的文本ART這49頁的文本我們可以看到其中有很多呈現的不是單純的這個關稅互惠而是多項足以影響我國主權的這個政策彈性的安排那許多條款在過去的經貿條款談判中也確實鮮少見到首先的話我們先來談談這個國防的部分"},{"start":74.076,"end":101.234,"text":"因為第五點四條我們可以看到第三項會將國防的年度預算應高於GDP的3%納入我們協議的文本那國防的預算本來就應該依照我們的安全情勢財政狀況跟我們國會審議的一個決定但是現在是透過貿易協定的方式予以拘束也限縮了我們未來政府的一個財政的一個編列的彈性跟我們立法監督的一個空間"},{"start":102.253,"end":107.571,"text":"那我們來看一下3%的GDP大概如果看起來大概至少要新台幣8500億元"},{"start":109.659,"end":132.837,"text":"那我們可以看一下我們115年度的這個軍事預算的組成因為我們用的是歐盟的這個計算方式所以我們可以看到包括國防部以及三項特別預算的退伏會海巡署跟非營業特種基金大概是9495億那未來美國如果不同意用歐盟的計算方式的話我們可能要扣掉退伏會的1064億"},{"start":134.585,"end":163.841,"text":"那還有包括新式戰機跟海空戰力提升這兩項因為今年就會執行完畢在扣掉這兩項之後大概有7只剩7700億左右那也就是說我們的公務預算未來還要再增加800億元才能夠達到8500億的規模所以想要編列到3%的GDP也勢必會影響到不管是教育啊社福啊或者是這個農業經濟以及基礎建設的這個資源喔所以要"},{"start":164.625,"end":186.471,"text":"那也讓我們這些年度預算是會受到外部的一個作用那也會削弱我們立法院審議跟這個財政自主的本身喔那所以國防支出喔應該是要依照我們的戰略需求跟財政能力來做一個彈性的調整但是像這樣子在商務協議中被寫死喔那放在商務的這個協議裡合理嗎"},{"start":189.344,"end":214.736,"text":"我剛剛看到文字的內容也應該清楚的看到它是TECO跟AIT宣誓一致這個宣誓一致表示我們是已經達到了我們已經達到了 所以我們宣誓說我們已經達到了3%因為94 95這個數字已經達到了3.32我們已經達到了 只是宣誓說未來會達到嗎未來我想隨著國家財政的能力跟國防的需求"},{"start":215.811,"end":231.989,"text":"對百分之三再往上增加看看我們的需求有多少我們的能力的支銷多少那因為你現在在協議文本裡面是寫寫清楚就是要至少要三趴嘛對不對對那未來如果沒有辦法達到是不是就本先說我們自己的一個財政的一個編列"},{"start":232.609,"end":261.701,"text":"國防支出的財政編列的一個能力那我們接下來再看一下我是不是跟委員做一點點補充因為這個條文其實它展明是一個我們談判前已經發生的事實也就是我國賴清德總統在去年的3月就已經宣示了這樣的一個國防預算的目標那談判是4月以後才開始的所以這個條文是一個展明我國已經總統宣示的一個目標跟事實所以未來也是會這樣子嗎沒有 這只是一個說跟我們所宣布的目標"},{"start":262.882,"end":272.575,"text":"這樣的一個事實宰民在條文裡面那如果說剛剛我提到這樣一個狀況勢必可能也會有些排擠到其他預算的一個狀況的時候那我們要怎麼樣來去因應排擠"},{"start":275.595,"end":295.643,"text":"報告委員 我們目前的確我們的國防預算就已經是朝這個目標在編列我們已經也向特別條例送到大院我們也希望 懇請大院能夠支持我們國防的特別條例就是我剛剛提到這個部分我是覺得那至於為什麼要在這個經貿所以這個是基於國家的 國防安全的目標對 那為什麼要在經貿的協議當中就加上這個 加上我們的這個國防的預算"},{"start":301.604,"end":309.551,"text":"這個是一個宰民事實我想這個只是表達說目前世界各國沒有這樣子我國自己已經有這樣的一個目標"},{"start":310.609,"end":338.985,"text":"另外我再請教一下就是在這個第五點一條裡面當美國以經濟安全為由制裁某國時台灣收到通知後必須要跟緊所以我們可以看到就是這樣的做法等於將我國是否對第三方採取貿易制裁的這個決策跟美方行動是綁定而且根據這個條款的話現在美國一直講說要制裁歐盟那如果他制裁歐盟的話我們也要跟進嗎"},{"start":340.287,"end":348.442,"text":"好這個我想在條文裡有這樣子的一個狀況那另外呢我再請院長看一下下面這張表就是針對台灣這個第五"},{"start":351.605,"end":379.112,"text":"我們這個協議裡面的5.2條第三項台灣的出口管制要跟美國的這個FDPR保持一致那未來美國的商務部如果他隨時修改這個規則那我們台灣也必須要自動跟進那未來如果損擊到台積電或是其他半導體大廠的重大利益時我們就沒有說部的權利只能當美國法律的這個執行窗口對台灣的廠商也非常的不公平那另外呢我們也可以看到"},{"start":379.571,"end":405.019,"text":"在這個3.2條的第三項就是有關醫藥主權就是未來只要經過美國FDA許可的我們就可以作為藥品在台上市那事實上我們都知道東方人跟西方人不管在基因在代謝上有所差異這個是醫學常識那現在美國FDA如果通過核准的就可以在台灣上市而不需要經過這個人體的試驗或任何臨床試驗的話"},{"start":408.24,"end":423.388,"text":"未來如果發生這樣子的一個這個爭議的話FDA會負責嗎尤其是過去在美國我們也曾經出過在美國通過卻在亞洲引發致命心律不整的這樣的一個案例那未來這樣的一個狀況的話誰要負責跟委員報告其實在這次談判中美國是對各國在談判那美國對許多國家都有提供ART這樣的一個這個各個條文的framework一起談"},{"start":435.655,"end":465.301,"text":"但是所以其实很多条件你可以比较各国所谈出来的也就是说各国都会放弃这样的健康主权吗在FDA的部分其实是FDA所许可作为我方审查的一个充分证据所以我方仍然保有相关的一个所以未来还是可以有人体试验还是可以有临床试验是吗那这个我们请部长可以来进一步说明跟委员说明这个美方跟我们的产品之间其实它是有区隔性所以我们它进来的大概都是比较高阶的"},{"start":465.711,"end":489.377,"text":"那麼在為了讓這個加速審查其實我們早就有一些加速審查的機制對於過去在一些我們認可的國家像FDA美國FDA或者是日本歐盟我現在就是要代表大家就是事宜的部分就是說未來是不是就是美國FDA這上市的就是最後到我們國家來我們還是可以我們還是可以經過人體實驗跟臨床實驗是嗎"},{"start":493.238,"end":519.326,"text":"我覺得這個部分對我們國人的健康安全非常的重要尤其是東西方人種的差異我們也希望說在這邊不要造成大家的誤解而是讓大家能夠知道針對這樣子的健康主權我們是有所堅持的絕對不會拿國人的健康開玩笑有兩重一個是它要符合美國FDA第二個是它作為我們充分的證據但是我方還是有一個審驗的程序持續進行那委員官卻那幾項衛福部都會持續把關"},{"start":519.966,"end":543.064,"text":"然後另外我們再看看第4.1條跟第4.4條就是全世界都在討論如何對Google Meta這些數位科技巨頭課稅然後我們在協議裡就是承諾不課徵數位服務稅甚至不能要求查閱原始碼那院長請問一下這樣的做法是不是犧牲我們的數位的主權那這樣子對於我們原來的稅收會犧牲多少呢"},{"start":544.395,"end":560.018,"text":"目前我國本來就沒有存在數位貿易稅世界各國都在討論嗎那你這是未來的趨勢我國本來現在就沒有對跨境平台徵收數位貿易稅那如果他涉及的話我們一般的像加值型營業稅或者是所得稅這些都還是有的"},{"start":560.939,"end":579.513,"text":"那現在是全世界都在討論嘛那為什麼我們要在條文裡就把它就是要求說不可以課徵數位封存所以我們陳述的是一個目前我們沒有這樣的一個對 那未來也不會有因為我們已經簽訂這樣子的一個條文那這一次在數位貿易裡面我想雙方很重要也達成這個"},{"start":580.994,"end":601.889,"text":"我們的這個邊境的自由傳輸那麼以及對於自由傳輸不課稅那最重要在資安安全上面的這個合作那我想台灣跟美國我們是自由民主的國家在數位貿易跟數位安全上面的合作其實是有它的一個重要性但是因為在這樣的條文裡我們就是未來是不可以對他們課徵這個數位服務稅"},{"start":603.55,"end":631.902,"text":"那未來如果當世界的趨勢做一個轉變我們必須做這樣的改變的時候那因為簽訂了這個ART之後我們就沒有辦法來跟他們課徵這樣子的一個稅收這樣是不是合理那因為全世界其實都在討論這樣的一個事情那另外呢我們也可以看到就這個部分的話除了這個部分我們大家國人非常關心的就是食安的問題那因為院長也常常講到說食安是政府的底線"},{"start":632.842,"end":661.634,"text":"所以從這份協議看起來其實政府顯然對於食安的這個問題做了一些的這個退縮我們首先先看到不好意思那可能這個部長可能可以我們現在要討論這個食安的問題我們可以看到就是現在我們針對這樣的我們針對有關不管是美豬美牛我們都做了一些退讓包括殘留標準我們不可以制定更"},{"start":662.459,"end":677.508,"text":"嚴格的一個規範所以我們現在是要跟Codex一致那另外呢還有就內臟部位的安排那我們可以看到就是說因為國人的這個飲食習慣跟西方人不同那這個殘留這個這對萊克多巴胺的殘留的這個"},{"start":679.157,"end":702.535,"text":"容許量我們把它放寬之後還有這個內臟的這個部位進口變多之後還有這個萊劑的部分我們都其實國人都非常擔心尤其是這個做業者的婦女或者是一些老人家或是學童那針對這樣的部分的話為什麼過去我們一直說這樣子是不行的它包括這個水解步驟恐怕我們現在也禁止採用水解步驟"},{"start":703.083,"end":714.164,"text":"因為會這個降低來季的檢出率那針對美豬的部分我們不能百分之百的這個要終止百分之百的"},{"start":715.221,"end":734.066,"text":"P的檢測那對美牛也要這個終止竹香的查驗等等這個都讓我們覺得針對食安的部分事實上尤其是美豬美牛來豬來牛對我們國人健康都會造成很大的一個影響那請問一下針對這個部分我們有什麼樣子的的說法"},{"start":735.738,"end":750.471,"text":"跟委員說明在食安的部分我們是嚴格把關這個原則是不變的但是我們跟國際接軌所以我們現在重新再去檢視我們對於特別是萊克多巴胺的殘留量跟CODES也就是所謂國際標準的"},{"start":752.253,"end":767.92,"text":"食品這個法典委員會所公布的標準我們重新評估同時也在去年我們已經完成了國人根據國人的飲食習慣所做的健康風險評估之後那麼認為可接受那所以我們現在呢重新調整的"},{"start":768.52,"end":787.098,"text":"標準除了跟Codex是一致之外也跟日本、韓國、新加坡是一致的那現在我們放棄了就百分之百的這個主批茶宴跟主香茶宴這個部分是不是會造成更多的輸入的管理我們從源頭包含茶廠包含系統性茶宴這個都還是照做的"},{"start":787.498,"end":811.648,"text":"那另外在這個條文他規範的是什麼補充補長就是說我們的這個在四大不變就是民間品項維持不變原產地標示不變校園優先採購國產不變以及食安管理機制不變就是源頭邊境後市場管理機制不變那原來因為他是不能進來的品項所以採用竹箱竹坯"},{"start":812.888,"end":831.489,"text":"那現在我們要回歸一般的我們的邊境的查驗所以我們還是有邊境查驗的程序所以我想這個部分就是剛剛部長講的這個部分我想部長在這個源頭邊境因為源頭就去茶廠系統性茶盒那為什麼要放棄像以前這樣百分之百的這個豬批查驗為什麼"},{"start":831.889,"end":860.93,"text":"因為就是回歸我們的既有的常態性的管理只是說我們常態性的管理的法規它沒有說一定要完全採明在我們的協議裡面但是在法規裡面都有其實也要代表我想所有全國的父母都非常擔心未來這樣子不管萊豬 藍牛會不會進入到這個營養午餐會不會進入到校園還有基改食品是會進入校園基改不會進入校園這個部分是大家現在非常擔心的疑慮因為很多的萊豬 藍牛它因為你的這個"},{"start":862.01,"end":890.57,"text":"放寬這個檢驗標準之後他可能就會利用其他的形式進來這是我們現在我想家長都非常擔心的郭文貴議員報告我們現在改變的這個標準跟國際接軌主要是在內臟肝腎的部分那肝腎在國內的使用量進口的佔量是非常非常低都在1%左右而已最後我想我要這個提出三點的這個嚴正的要求"},{"start":891.155,"end":915.592,"text":"第一個就是要盡速送立法院實質的審議因為過去這個政府院長在擔任委員的時候也有特別說要拒絕行政獨裁那另外還有拒絕黑箱作業我們也是要落實政府院長當年主張要公開透明第三個我們也希望能夠盡速的提出產業的衝擊評估報告不可以拿這個台灣的主權"},{"start":916.497,"end":923.121,"text":"跟國人健康為犧牲所以在這邊也要特別的要求希望我們能夠落實這三樣的要求"}],"gazette":[{"speaker":"許委員宇甄","start":"2026-03-03T16:34:55.814000+08:00","guessed":false,"end":"2026-03-03T16:34:59.327000+08:00","text":"謝謝院長，我們請卓榮泰卓院長。","quality":1},{"speaker":"主席","start":"2026-03-03T16:34:59.327000+08:00","guessed":false,"end":"2026-03-03T16:34:59.909000+08:00","text":"麻煩再請卓院長備詢。","quality":1},{"speaker":"卓院長榮泰","start":"2026-03-03T16:35:10.333000+08:00","guessed":false,"end":"2026-03-03T16:35:10.473000+08:00","text":"許委員好。","quality":0.75},{"speaker":"許委員宇甄","start":"2026-03-03T16:35:11.394000+08:00","guessed":false,"end":"2026-03-03T16:35:11.394000+08:00","text":"卓院長好。","quality":0.5},{"speaker":"許委員宇甄","start":"2026-03-03T16:35:12.894000+08:00","guessed":false,"end":"2026-03-03T16:36:04.437000+08:00","text":"卓院長，這段時間以來，行政院一直以我們這次談判是重大突破，以及強調它的成果和紅利，當然針對這個部分，我想政策評價不是只有我們自己大內宣，還是應該回歸到雙方條文本身是不是權利義務對等，還有風險是不是可以控管，因為在ART 49頁的文本中，我們可以看到其中有很多呈現的不是單純的關稅互惠，而是多項足以影響我國主權政策的彈性安排，許多條款在過去的經貿談判中也確實鮮少見到，所以首先我們來談談國防的部分。","quality":0.901},{"speaker":"許委員宇甄","start":"2026-03-03T16:36:05.336000+08:00","guessed":false,"end":"2026-03-03T16:36:32.234000+08:00","text":"第5.4條第3項將年度國防預算編列應高於GDP 3%納入了協議文本，國防預算本來是應該依照我們的安全情勢、財政狀況跟國會審議來決定，但現在是透過貿易協定的方式予以拘束，限縮了政府未來財政編列的彈性跟立法監督的空間。","quality":0.897},{"speaker":"許委員宇甄","start":"2026-03-03T16:36:34.658000+08:00","guessed":false,"end":"2026-03-03T16:37:57.471000+08:00","text":"3%的GDP大概至少要新臺幣8,500億元，我們可以看一下115年度我國軍事預算的組成，因為我們用的是歐盟的計算方式，所以可以看到包括國防部三項特別預算，以及退輔會、海巡署和非營業特種基金，大概是9,495億，未來美國如果不同意用歐盟的計算方式，可能要扣掉退輔會的1,064億，還有包括新式戰機跟海空戰力提升這兩項的預算，因為這個今年就會執行完畢，扣掉這兩項之後大概只剩7,700億左右，也就是說，我們的公務預算未來還要再增加800億元才能夠達到8,500億的規模，所以想要編列到3%的GDP勢必會影響到不管是教育、社福，或者是農業、經濟以及基礎建設的資源，讓我們這些年度預算受到外部左右，也會削弱我們立法院的審議跟國家財政自主權，我想國防支出應該要依照我國的戰略需求跟財政能力來做彈性調整，但是像這樣子在商務談判中被寫死放在商務協議裡，合理嗎？","quality":0.913},{"speaker":"卓院長榮泰","start":"2026-03-03T16:38:00.844000+08:00","guessed":false,"end":"2026-03-03T16:38:18.412000+08:00","text":"委員在剛剛的文字內容裡應該也清楚看到，它是TECRO跟AIT宣示一致，這個宣示一致表示我們已經達到了，所以是宣示我們已經達到3%，因為9,495這個數字已經達到3.32%，我們已經達到了，只是……","quality":0.841},{"speaker":"許委員宇甄","start":"2026-03-03T16:38:18.773000+08:00","guessed":false,"end":"2026-03-03T16:38:20.693000+08:00","text":"但未來會達到嗎？","quality":0.857},{"speaker":"卓院長榮泰","start":"2026-03-03T16:38:20.693000+08:00","guessed":false,"end":"2026-03-03T16:38:22.574000+08:00","text":"未來我想隨著……","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:38:22.574000+08:00","guessed":true,"end":"2026-03-03T16:38:23.574000+08:00","text":"就是我剛剛提到的這個部分？","quality":0},{"speaker":"卓院長榮泰","start":"2026-03-03T16:38:22.814000+08:00","guessed":false,"end":"2026-03-03T16:38:32.056000+08:00","text":"國家財政能力跟國防需求，3%再往上增加，看看我們的需求有多少，我們的能力能支持多少……","quality":0.919},{"speaker":"許委員宇甄","start":"2026-03-03T16:38:32.957000+08:00","guessed":false,"end":"2026-03-03T16:38:38.464000+08:00","text":"現在協議文本裡是清楚寫著至少要3%，對不對？","quality":0.842},{"speaker":"許委員宇甄","start":"2026-03-03T16:38:38.624000+08:00","guessed":false,"end":"2026-03-03T16:38:45.550000+08:00","text":"未來如果沒有辦法達到，是不是就等於限縮我們自己國防支出的財政編列能力？","quality":0.879},{"speaker":"許委員宇甄","start":"2026-03-03T16:38:46.350000+08:00","guessed":false,"end":"2026-03-03T16:38:47.131000+08:00","text":"接下來我們再看一下……","quality":0.778},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:38:47.931000+08:00","guessed":false,"end":"2026-03-03T16:39:04.297000+08:00","text":"跟委員做一點點補充，這個條文其實載明的是一個我們談判前就已經發生的事實，也就是我國賴清德總統在去年3月就已經宣示這樣一個國防預算的目標，而談判是4月以後才開始，所以這個條文是載明……","quality":0.94},{"speaker":"許委員宇甄","start":"2026-03-03T16:39:04.297000+08:00","guessed":true,"end":"2026-03-03T16:39:05.297000+08:00","text":"所以未來……","quality":0},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:39:04.898000+08:00","guessed":false,"end":"2026-03-03T16:39:07.879000+08:00","text":"我國已經經總統宣示的一個目標跟事實，而現在已經是這樣編列……","quality":0.593},{"speaker":"許委員宇甄","start":"2026-03-03T16:39:07.879000+08:00","guessed":false,"end":"2026-03-03T16:39:10.360000+08:00","text":"所以未來也會是這樣子嗎？","quality":0.909},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:39:10.360000+08:00","guessed":false,"end":"2026-03-03T16:39:15.524000+08:00","text":"沒有，這只是一個我們所宣示的目標和這樣一個事實載明在條文裡面。","quality":0.862},{"speaker":"許委員宇甄","start":"2026-03-03T16:39:16.586000+08:00","guessed":false,"end":"2026-03-03T16:39:23.555000+08:00","text":"如果像剛剛我提到的狀況，就是勢必可能會排擠到其他預算時，我們要怎麼因應？","quality":0.879},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:39:26.595000+08:00","guessed":false,"end":"2026-03-03T16:39:36.139000+08:00","text":"報告委員，目前的確我們的國防預算已經是朝這個目標在編列，我們也已經把特別條例送到大院，也懇請、希望大院能夠支持我們的國防特別條例……","quality":0.917},{"speaker":"許委員宇甄","start":"2026-03-03T16:39:36.259000+08:00","guessed":false,"end":"2026-03-03T16:39:38.060000+08:00","text":"就是我剛剛提到的這個部分，我是覺得……","quality":0.938},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:39:38.060000+08:00","guessed":true,"end":"2026-03-03T16:39:39.220000+08:00","text":"這個是對於國家提升自我防衛能力非常重要的……","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:39:39.220000+08:00","guessed":false,"end":"2026-03-03T16:39:41.161000+08:00","text":"至於為什麼要在經貿……","quality":1},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:39:41.161000+08:00","guessed":false,"end":"2026-03-03T16:39:45.002000+08:00","text":"所以這個是基於國家國防安全的目標跟我國的利益，總統所宣示的一個目標。","quality":0.5},{"speaker":"許委員宇甄","start":"2026-03-03T16:39:45.002000+08:00","guessed":false,"end":"2026-03-03T16:39:46.623000+08:00","text":"對，那為什麼要在經貿協議當中加上這個國防預算的GDP？","quality":0.84},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:39:52.604000+08:00","guessed":false,"end":"2026-03-03T16:39:55.907000+08:00","text":"這只是一個載明事實，我想這個只是表達說……","quality":0.833},{"speaker":"許委員宇甄","start":"2026-03-03T16:39:55.907000+08:00","guessed":false,"end":"2026-03-03T16:39:58.309000+08:00","text":"目前好像世界各國沒有這樣子吧！","quality":0.786},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:39:58.649000+08:00","guessed":false,"end":"2026-03-03T16:40:00.551000+08:00","text":"美方政府了解到我國政府自己已經有這樣的一個目標。好。","quality":0.583},{"speaker":"許委員宇甄","start":"2026-03-03T16:40:01.609000+08:00","guessed":false,"end":"2026-03-03T16:40:11.555000+08:00","text":"另外，我再請教一下，在第5.1條裡面，當美國以經濟安全為由制裁某國時，臺灣收到通知後必須要跟進。","quality":0.951},{"speaker":"許委員宇甄","start":"2026-03-03T16:40:12.315000+08:00","guessed":false,"end":"2026-03-03T16:40:22.381000+08:00","text":"所以我們可以看到這樣的做法等於將我國是否對第三方採取貿易制裁的這個決策跟美方的行動是綁定的。","quality":0.956},{"speaker":"許委員宇甄","start":"2026-03-03T16:40:22.901000+08:00","guessed":false,"end":"2026-03-03T16:40:29.985000+08:00","text":"而且根據這個條款，現在美國一直講要制裁歐盟，如果他制裁歐盟的話，我們也要跟進嗎？","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:40:31.568000+08:00","guessed":false,"end":"2026-03-03T16:40:34.633000+08:00","text":"我想這在條文裡有這樣子的一個狀況。","quality":0.938},{"speaker":"許委員宇甄","start":"2026-03-03T16:40:34.774000+08:00","guessed":false,"end":"2026-03-03T16:40:49.827000+08:00","text":"另外，我再請院長看一下下面的這張表，在這個協議裡面的第5.2條第3項，臺灣的出口管制要跟美國的FDPR保持一致。","quality":0.939},{"speaker":"許委員宇甄","start":"2026-03-03T16:40:50.527000+08:00","guessed":false,"end":"2026-03-03T16:41:08.191000+08:00","text":"未來美國的商務部如果隨時修改這些規則，我們臺灣也必須要自動跟進，因此未來如果損及到台積電或是其他半導體大廠的重大利益時，我們就沒有說不的權力，只能當美國法律的執行窗口，對臺灣的廠商也非常不公平。","quality":0.923},{"speaker":"許委員宇甄","start":"2026-03-03T16:41:08.892000+08:00","guessed":false,"end":"2026-03-03T16:41:22.195000+08:00","text":"另外我們也可以看到第3.2條第3項，就是有關醫藥主權的部分，未來只要經過美國FDA許可的我們就可以作為藥品在臺上市。","quality":0.923},{"speaker":"許委員宇甄","start":"2026-03-03T16:41:22.975000+08:00","guessed":false,"end":"2026-03-03T16:41:30.317000+08:00","text":"事實上我們都知道，東方人跟西方人不管在基因、在代謝上有所差異，這個是醫學常識。","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:41:30.917000+08:00","guessed":false,"end":"2026-03-03T16:41:44.803000+08:00","text":"現在美國FDA如果通過核准的就可以在臺灣上市，而不需要經過人體的試驗或任何臨床試驗的話，未來如果發生爭議的話，FDA會負責嗎？","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:41:44.803000+08:00","guessed":false,"end":"2026-03-03T16:41:52.147000+08:00","text":"尤其是過去也曾經出現過在美國通過卻在亞洲引發致命的心律不整的一個案例，未來有這樣的狀況的話，誰要負責？","quality":0.938},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:41:52.147000+08:00","guessed":false,"end":"2026-03-03T16:42:09.936000+08:00","text":"跟委員報告，其實在這次談判中美國是對各國在談判，美國對許多國家都有提供ART這樣的一個……各個條文的framework一起談，所以有很多條文你其實可以比較各國最終所談出來的結果。","quality":0.843},{"speaker":"許委員宇甄","start":"2026-03-03T16:42:10.476000+08:00","guessed":false,"end":"2026-03-03T16:42:12.916000+08:00","text":"所以也就是說各國都會放棄這樣的健康主權嗎？","quality":0.5},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:42:13.036000+08:00","guessed":false,"end":"2026-03-03T16:42:21.698000+08:00","text":"有關這一條在FDA的部分，其實是FDA許可作為我方審查的一個充分證據，所以我方仍然保有相關的審驗程序。","quality":0.646},{"speaker":"許委員宇甄","start":"2026-03-03T16:42:21.938000+08:00","guessed":false,"end":"2026-03-03T16:42:25.619000+08:00","text":"所以未來還是可以有人體試驗，還是可以有臨床試驗是嗎？","quality":0.583},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:42:25.619000+08:00","guessed":true,"end":"2026-03-03T16:42:26.949000+08:00","text":"當然，我們還是有審驗的程序，這個我們請部長進一步說明。","quality":0.208},{"speaker":"卓院長榮泰","start":"2026-03-03T16:42:26.949000+08:00","guessed":true,"end":"2026-03-03T16:42:28.279000+08:00","text":"請部長來說明一下。","quality":0},{"speaker":"石部長崇良","start":"2026-03-03T16:42:28.279000+08:00","guessed":false,"end":"2026-03-03T16:42:36.281000+08:00","text":"跟委員說明，美方跟我們的產品之間其實是有區隔性的，它進來的大概都是比較高階的。","quality":0.667},{"speaker":"石部長崇良","start":"2026-03-03T16:42:37.851000+08:00","guessed":false,"end":"2026-03-03T16:42:48.314000+08:00","text":"為了讓這個加速審查，其實我們早就有一些加速審查的機制，對於過去一些我們認可的國家，像美國FDA或者是日本、歐盟，都有同樣的這個……","quality":0.879},{"speaker":"許委員宇甄","start":"2026-03-03T16:42:48.394000+08:00","guessed":false,"end":"2026-03-03T16:42:56.256000+08:00","text":"我現在就是要代表大家要求釋疑，未來是不是只要美國FDA核准上市的……","quality":0.742},{"speaker":"石部長崇良","start":"2026-03-03T16:42:56.256000+08:00","guessed":true,"end":"2026-03-03T16:42:57.256000+08:00","text":"最後的決定權還是在我們。","quality":0.091},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:42:57.256000+08:00","guessed":true,"end":"2026-03-03T16:42:58.256000+08:00","text":"最後的決定權還是在我們的程序……","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:42:57.016000+08:00","guessed":false,"end":"2026-03-03T16:43:00.377000+08:00","text":"最後到我們國家來，我們還是可以經過人體試驗跟臨床試驗是嗎？","quality":0.926},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:43:00.377000+08:00","guessed":true,"end":"2026-03-03T16:43:02.307500+08:00","text":"它只是作為一個公正的證據。","quality":0},{"speaker":"石部長崇良","start":"2026-03-03T16:43:02.307500+08:00","guessed":true,"end":"2026-03-03T16:43:04.238000+08:00","text":"我們會去檢視是不是有……","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:43:04.238000+08:00","guessed":false,"end":"2026-03-03T16:43:11.881000+08:00","text":"我覺得這個部分對我們國人的健康安全非常重要，尤其是東西方有人種的差異，我們也希望在這邊不要造成大家的誤解。不會。","quality":0.942},{"speaker":"許委員宇甄","start":"2026-03-03T16:43:12.361000+08:00","guessed":false,"end":"2026-03-03T16:43:20.183000+08:00","text":"而是讓大家能夠知道針對這樣的健康主權我們是有所堅持的，絕對不會拿國人的健康開玩笑。對。","quality":0.975},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:43:20.403000+08:00","guessed":false,"end":"2026-03-03T16:43:27.505000+08:00","text":"第二個就是有兩重，一個是要符合美國FDA，第二個是它作為我們充分的證據，但是我方還是有一個審驗的程序持續進行。","quality":0.902},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:43:28.085000+08:00","guessed":false,"end":"2026-03-03T16:43:30.326000+08:00","text":"至於委員關切的那幾項，衛福部都會持續把關。","quality":0.737},{"speaker":"許委員宇甄","start":"2026-03-03T16:43:31.126000+08:00","guessed":false,"end":"2026-03-03T16:43:46.938000+08:00","text":"另外我們再看看第4.1條跟第4.4條，全世界都在討論如何對Google、Meta這些數位科技巨頭課稅，我們在協議裡承諾不課徵數位服務稅，甚至不能要求查閱原始碼。","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:43:47.379000+08:00","guessed":false,"end":"2026-03-03T16:43:51.041000+08:00","text":"院長請問一下，這樣的做法是不是犧牲了我們的數位主權？","quality":0.958},{"speaker":"許委員宇甄","start":"2026-03-03T16:43:51.462000+08:00","guessed":false,"end":"2026-03-03T16:43:54.044000+08:00","text":"這樣對我們原來的稅收會犧牲多少呢？","quality":1},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:43:55.395000+08:00","guessed":false,"end":"2026-03-03T16:43:58.700000+08:00","text":"目前我國本來就沒有存在數位貿易稅。對。","quality":0.941},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:43:58.700000+08:00","guessed":true,"end":"2026-03-03T16:43:59.700000+08:00","text":"我們是針對平台……","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:43:58.700000+08:00","guessed":false,"end":"2026-03-03T16:44:01.804000+08:00","text":"但是世界各國都在討論，這也是未來的趨勢。","quality":0.833},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:44:01.804000+08:00","guessed":false,"end":"2026-03-03T16:44:10.998000+08:00","text":"我國現在本來就沒有對跨境平台徵收數位貿易稅，如果它有涉及的話，我們一般會有像加值型營業稅，或者是所得稅，這些也都還是有的，我們國內這些稅制都沒有影響。","quality":0.696},{"speaker":"許委員宇甄","start":"2026-03-03T16:44:12.299000+08:00","guessed":false,"end":"2026-03-03T16:44:13.580000+08:00","text":"但現在是全世界都在討論，希望還是要有這樣的一個……對。","quality":0.435},{"speaker":"許委員宇甄","start":"2026-03-03T16:44:15.302000+08:00","guessed":false,"end":"2026-03-03T16:44:20.145000+08:00","text":"為什麼要在條文裡要求不可以課徵數位服務稅？","quality":0.85},{"speaker":"卓院長榮泰","start":"2026-03-03T16:44:20.145000+08:00","guessed":true,"end":"2026-03-03T16:44:21.145000+08:00","text":"就是維持現狀。","quality":0},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:44:20.606000+08:00","guessed":false,"end":"2026-03-03T16:44:24.609000+08:00","text":"對，就只是維持現狀，所以我們陳述的是目前我們沒有這樣的數位貿易稅。","quality":0.567},{"speaker":"許委員宇甄","start":"2026-03-03T16:44:25.629000+08:00","guessed":false,"end":"2026-03-03T16:44:27.771000+08:00","text":"但未來也不會有，因為我們已經簽訂這樣子的條文了嘛！","quality":0.87},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:44:28.011000+08:00","guessed":false,"end":"2026-03-03T16:44:37.118000+08:00","text":"這一次在數位貿易裡面，我想雙方很重要的是達成了邊境的自由傳輸以及對於自由傳輸不課稅。","quality":0.925},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:44:37.218000+08:00","guessed":false,"end":"2026-03-03T16:44:39.580000+08:00","text":"最重要的是在資安安全上面的合作。","quality":0.867},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:44:40.420000+08:00","guessed":false,"end":"2026-03-03T16:44:48.786000+08:00","text":"我想臺灣跟美國是自由、民主的國家，在數位貿易跟數位安全上面的合作其實是有它的一個重要性跟這個……","quality":0.932},{"speaker":"許委員宇甄","start":"2026-03-03T16:44:49.867000+08:00","guessed":false,"end":"2026-03-03T16:45:04.774000+08:00","text":"但是因為在這樣的條文裡，我們未來就是不可以對他們課徵這個數位服務稅，如果未來世界的趨勢轉變，我們必須做這樣的改變，卻因為簽訂了這個ART，我們就沒有辦法來跟他們課徵這樣的稅收，這樣是不是合理？","quality":0.955},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:05.595000+08:00","guessed":false,"end":"2026-03-03T16:45:08.056000+08:00","text":"全世界其實都在討論這樣的事情。","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:08.936000+08:00","guessed":false,"end":"2026-03-03T16:45:17.860000+08:00","text":"另外，我們也可以看到，除了這個部分，我們國人非常關心的就是食安的問題。","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:20.581000+08:00","guessed":false,"end":"2026-03-03T16:45:33.126000+08:00","text":"雖然院長也常常講到食安是政府的底線，但是從這份協議看起來，政府顯然對於食安這個問題做了一些退縮。","quality":0.911},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:33.126000+08:00","guessed":false,"end":"2026-03-03T16:45:34.186000+08:00","text":"我們首先看到……","quality":1},{"speaker":"卓院長榮泰","start":"2026-03-03T16:45:34.186000+08:00","guessed":true,"end":"2026-03-03T16:45:35.186000+08:00","text":"並沒有、並沒有。","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:35.027000+08:00","guessed":false,"end":"2026-03-03T16:45:35.387000+08:00","text":"不好意思！","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:36.847000+08:00","guessed":false,"end":"2026-03-03T16:45:39.368000+08:00","text":"部長可以上來，我們現在要討論食安的問題。","quality":0.889},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:39.368000+08:00","guessed":false,"end":"2026-03-03T16:45:57.101000+08:00","text":"我們可以看到，現在我們這樣的ART針對不管是有關美豬或美牛都做了一些退讓，包括殘留標準，我們不可以自訂更嚴格的規範，我們現在是要跟Codex一致。","quality":0.882},{"speaker":"許委員宇甄","start":"2026-03-03T16:45:57.982000+08:00","guessed":false,"end":"2026-03-03T16:46:24.248000+08:00","text":"另外，就內臟部位的安排我們可以看到，因為國人的飲食習慣跟西方人不同，我們對萊克多巴胺的殘留容許量放寬之後，以及內臟這個部位進口變多之後，還有萊劑的部分，國人都非常擔心，尤其不管是做月子的婦女，或者是老人家，或者是學童。","quality":0.909},{"speaker":"許委員宇甄","start":"2026-03-03T16:46:25.448000+08:00","guessed":false,"end":"2026-03-03T16:47:00.985000+08:00","text":"針對這樣的部分，過去我們一直說這樣是不行的，還有包括水解步驟，我們現在也禁止採用水解步驟，因為會降低萊劑的檢出率，針對美豬的部分，我們要終止百分之百逐批檢測，對於美牛也要終止逐箱查驗等等，這個都讓我們覺得對食安的部分會造成很大的影響，尤其是美豬、美牛、萊豬、萊牛對我們國人健康都會造成很大的影響。","quality":0.859},{"speaker":"許委員宇甄","start":"2026-03-03T16:47:01.445000+08:00","guessed":false,"end":"2026-03-03T16:47:05.046000+08:00","text":"請問一下，針對這個部分我們有什麼樣的說法？","quality":1},{"speaker":"卓院長榮泰","start":"2026-03-03T16:47:05.046000+08:00","guessed":true,"end":"2026-03-03T16:47:06.738000+08:00","text":"請部長說明。","quality":0},{"speaker":"石部長崇良","start":"2026-03-03T16:47:06.738000+08:00","guessed":false,"end":"2026-03-03T16:47:44.805000+08:00","text":"跟委員說明，在食安的部分我們是嚴格把關，這個原則是不變的，但是我們跟國際接軌，所以我們現在重新再去檢視，特別是我們對於萊克多巴胺的殘留量跟Codex（國際食品法典委員會）所公布的標準，我們重新評估，同時去年我們完成根據國人的飲食習慣所做的健康風險評估之後認為可接受，所以我們現在重新調整的標準除了跟Codex是一致的之外，也跟日本、韓國、新加坡是一致的……","quality":0.951},{"speaker":"許委員宇甄","start":"2026-03-03T16:47:45.126000+08:00","guessed":false,"end":"2026-03-03T16:47:51.311000+08:00","text":"現在我們放棄了百分之百逐批查驗與逐箱查驗，這個部分是不是會造成更多的萊豬……","quality":0.714},{"speaker":"石部長崇良","start":"2026-03-03T16:47:51.492000+08:00","guessed":false,"end":"2026-03-03T16:47:55.816000+08:00","text":"這個輸入的管理我們從源頭，包含查廠、包含系統性查驗……對。","quality":0.75},{"speaker":"石部長崇良","start":"2026-03-03T16:47:57.177000+08:00","guessed":false,"end":"2026-03-03T16:47:58.078000+08:00","text":"都還是照做的。","quality":1},{"speaker":"石部長崇良","start":"2026-03-03T16:47:58.618000+08:00","guessed":false,"end":"2026-03-03T16:47:58.978000+08:00","text":"另外在邊境的管理與……","quality":0.333},{"speaker":"許委員宇甄","start":"2026-03-03T16:48:00.779000+08:00","guessed":false,"end":"2026-03-03T16:48:04.360000+08:00","text":"那這個條文規範的是什麼？","quality":0.909},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:04.360000+08:00","guessed":true,"end":"2026-03-03T16:48:05.360000+08:00","text":"報告，我是不是補充部長講的？","quality":0.25},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:04.961000+08:00","guessed":false,"end":"2026-03-03T16:48:19.106000+08:00","text":"就是我們有四大不變在守護國民健康，包括敏感品項維持不變、原產地標示不變、校園優先採購國產不變，以及食安管理機制不變，就是源頭、邊境以及後市場管理機制不變。","quality":0.814},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:19.246000+08:00","guessed":false,"end":"2026-03-03T16:48:29.514000+08:00","text":"原來因為它是不能進來的品項，所以採用逐箱逐批，現在我們要回歸我們一般的邊境查驗，所以我們還是有邊境查驗的程序……對。","quality":0.865},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:30.656000+08:00","guessed":false,"end":"2026-03-03T16:48:32.057000+08:00","text":"我想這個部分就是剛剛部長講的……","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:48:32.438000+08:00","guessed":false,"end":"2026-03-03T16:48:33.178000+08:00","text":"這個部分，我想部長……","quality":1},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:33.178000+08:00","guessed":false,"end":"2026-03-03T16:48:36.802000+08:00","text":"在源頭、邊境，源頭就是去查廠、系統性查核，邊境也有一般的……","quality":0.542},{"speaker":"許委員宇甄","start":"2026-03-03T16:48:37.964000+08:00","guessed":false,"end":"2026-03-03T16:48:42.469000+08:00","text":"那為什麼要放棄像以前這樣百分之百的逐批查驗？","quality":0.952},{"speaker":"許委員宇甄","start":"2026-03-03T16:48:42.469000+08:00","guessed":false,"end":"2026-03-03T16:48:42.489000+08:00","text":"為什麼？","quality":1},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:42.889000+08:00","guessed":false,"end":"2026-03-03T16:48:45.671000+08:00","text":"因為就是回歸我們既有的常態性管理……","quality":0.875},{"speaker":"石部長崇良","start":"2026-03-03T16:48:45.671000+08:00","guessed":true,"end":"2026-03-03T16:48:46.792000+08:00","text":"就回歸到常態性管理。","quality":0.222},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:46.792000+08:00","guessed":false,"end":"2026-03-03T16:48:51.915000+08:00","text":"只是我們常態性管理的法規沒有一定要完全載明在我們的協議裡面……","quality":0.966},{"speaker":"許委員宇甄","start":"2026-03-03T16:48:51.915000+08:00","guessed":true,"end":"2026-03-03T16:48:52.915000+08:00","text":"所以在這邊本席也要代表……","quality":0},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:52.136000+08:00","guessed":false,"end":"2026-03-03T16:48:52.956000+08:00","text":"但是在法規裡面都有，在法規裡面都有。","quality":0.562},{"speaker":"許委員宇甄","start":"2026-03-03T16:48:53.937000+08:00","guessed":false,"end":"2026-03-03T16:48:58.820000+08:00","text":"我想全國所有父母都非常擔心未來這樣，不管萊豬或萊牛……","quality":0.833},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:48:58.820000+08:00","guessed":true,"end":"2026-03-03T16:48:59.820000+08:00","text":"不會，這個食安管理制度……","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:48:59.561000+08:00","guessed":false,"end":"2026-03-03T16:49:01.102000+08:00","text":"會不會進入到營養午餐？","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:49:01.382000+08:00","guessed":false,"end":"2026-03-03T16:49:03.123000+08:00","text":"會不會進入到校園？","quality":1},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:49:03.123000+08:00","guessed":true,"end":"2026-03-03T16:49:04.123000+08:00","text":"不會，校園都……","quality":0},{"speaker":"石部長崇良","start":"2026-03-03T16:49:04.123000+08:00","guessed":true,"end":"2026-03-03T16:49:05.123000+08:00","text":"校園都還是優先採購國產的。","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:49:03.123000+08:00","guessed":false,"end":"2026-03-03T16:49:05.545000+08:00","text":"還有基改食品是不是會進入校園？","quality":0.857},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:49:05.545000+08:00","guessed":false,"end":"2026-03-03T16:49:07.687000+08:00","text":"基改食品不會進入校園。","quality":0.8},{"speaker":"石部長崇良","start":"2026-03-03T16:49:07.687000+08:00","guessed":true,"end":"2026-03-03T16:49:08.687000+08:00","text":"基改的管理不變。","quality":0},{"speaker":"許委員宇甄","start":"2026-03-03T16:49:07.687000+08:00","guessed":false,"end":"2026-03-03T16:49:21.216000+08:00","text":"這個部分是大家現在非常擔心的疑慮，因為很多萊豬、萊牛因為你放寬這個檢驗標準之後可能就會利用其他的形式進來，我想這是現在家長都非常擔心的……","quality":0.953},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:49:21.216000+08:00","guessed":true,"end":"2026-03-03T16:49:22.737000+08:00","text":"因為現在校園有共同供應契約，優先採購國產不變。","quality":0},{"speaker":"石部長崇良","start":"2026-03-03T16:49:22.737000+08:00","guessed":false,"end":"2026-03-03T16:49:35.726000+08:00","text":"跟委員報告，我們現在改變的這個標準跟國際接軌主要是在內臟、肝、腎的部分，就肝、腎在國內的使用量，進口的占量是非常非常低，都在1%左右而已。","quality":0.933},{"speaker":"許委員宇甄","start":"2026-03-03T16:49:36.166000+08:00","guessed":false,"end":"2026-03-03T16:49:41.550000+08:00","text":"最後，我要提出三點嚴正的要求。","quality":1},{"speaker":"許委員宇甄","start":"2026-03-03T16:49:42.155000+08:00","guessed":false,"end":"2026-03-03T16:49:59.026000+08:00","text":"第一個，就是要儘速送立法院實質審議，因為過去鄭副院長在擔任委員的時候也有特別說要拒絕行政獨裁，另外還有拒絕黑箱作業，我們也是要落實鄭副院長當年主張的要公開透明。","quality":0.92},{"speaker":"許委員宇甄","start":"2026-03-03T16:49:59.647000+08:00","guessed":false,"end":"2026-03-03T16:50:09.198000+08:00","text":"第三個，我們也希望能夠儘速提出產業的衝擊評估報告，不可以拿臺灣的主權跟國人健康作為犧牲。","quality":0.951},{"speaker":"許委員宇甄","start":"2026-03-03T16:50:09.759000+08:00","guessed":false,"end":"2026-03-03T16:50:14.101000+08:00","text":"所以在這邊也要特別的要求，希望能夠落實這三樣要求。","quality":1},{"speaker":"鄭副院長麗君","start":"2026-03-03T16:50:14.601000+08:00","guessed":true,"end":"2026-03-03T16:50:18.886714+08:00","text":"一定是經過國會公開議決才會生效。","quality":0},{"speaker":"卓院長榮泰","start":"2026-03-03T16:50:19.186714+08:00","guessed":true,"end":"2026-03-03T16:50:20.615286+08:00","text":"對，謝謝委員。","quality":0},{"speaker":"主席","start":"2026-03-03T16:50:20.915286+08:00","guessed":true,"end":"2026-03-03T16:50:28.343857+08:00","text":"謝謝許宇甄委員質詢，謝謝卓院長、鄭副院長、相關部會首長備詢。","quality":0},{"speaker":"主席","start":"2026-03-03T16:50:28.643857+08:00","guessed":true,"end":"2026-03-03T16:50:38.643857+08:00","text":"接下來登記第17號的王定宇委員改書面提出，請行政院書面答復，並列入紀錄，刊登公報。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:50:38.943857+08:00","guessed":true,"end":"2026-03-03T16:50:47.801000+08:00","text":"一、關於美國突發關稅變局，白宮啟動122條款對全球課徵最多150天的暫時性關稅。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:50:48.101000+08:00","guessed":true,"end":"2026-03-03T16:50:59.815286+08:00","text":"建請行政院說明，在美國最高法院推翻IEEPA後，台美對等貿易協定（ART）目前是否仍然有效？","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:51:00.115286+08:00","guessed":true,"end":"2026-03-03T16:51:06.401000+08:00","text":"面對這最多150天的122條款關稅，政府的具體因應對策為何？","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:51:06.701000+08:00","guessed":true,"end":"2026-03-03T16:51:22.986714+08:00","text":"二、關於122條款臨時關稅對我國產業之衝擊，以蝴蝶蘭為例，在ART協定下原可享零關稅，但122條款臨時關稅需面臨15%疊加最惠國稅率（MFN）。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:51:23.286714+08:00","guessed":true,"end":"2026-03-03T16:51:37.858143+08:00","text":"白宮122條款僅對全球維持230項豁免，台灣在ART中成功爭取到的額外27項專屬豁免（包含蝴蝶蘭）均不在白宮的全球豁免清單內。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:51:38.158143+08:00","guessed":true,"end":"2026-03-03T16:51:44.729571+08:00","text":"若不加速審查台美ART，台灣農產品恐面臨極大困境。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:51:45.029571+08:00","guessed":true,"end":"2026-03-03T16:51:56.172429+08:00","text":"建請行政院具體說明，將如何協助農產業者度過難關，並確保我國農業專屬豁免權益不受損害。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:51:56.472429+08:00","guessed":true,"end":"2026-03-03T16:52:16.186714+08:00","text":"三、關於美國貿易代表署（USTR）甫公布2026年貿易政策，表示今年將尋求進一步降低外國關稅和非關稅壁壘，執行其「互惠」貿易協定，並考慮啟動新的不公平貿易行為調查。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:52:16.486714+08:00","guessed":true,"end":"2026-03-03T16:52:22.486714+08:00","text":"建請行政院說明，台美ART預定何時能正式生效？","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:52:22.786714+08:00","guessed":true,"end":"2026-03-03T16:52:31.929571+08:00","text":"面對美方未來的議程設定與可能的新調查，政府的研判與準備因應措施為何？","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:52:32.229571+08:00","guessed":true,"end":"2026-03-03T16:52:52.801000+08:00","text":"四、關於半導體及關鍵產業防線，我國是唯一明確爭取到半導體及衍生品優惠（配額內0%）的國家，且此權利已納入台美投資合作備忘錄（MOU）協商機制，不因美國法院判決喪失。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:52:53.101000+08:00","guessed":true,"end":"2026-03-03T16:53:02.243857+08:00","text":"我國也已透過MOU爭取到232條款（如汽車零組件、鋼鐵鋁等）各項之最惠國待遇。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:53:02.543857+08:00","guessed":true,"end":"2026-03-03T16:53:14.829571+08:00","text":"然而，若美方未來增加232條款調查項目，或啟動301條款調查，現行透過MOU取得的優惠稅制是否會受到衝擊？","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:53:15.129571+08:00","guessed":true,"end":"2026-03-03T16:53:18.272429+08:00","text":"建請行政院備妥應對方案。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:53:18.572429+08:00","guessed":true,"end":"2026-03-03T16:53:38.858143+08:00","text":"五、關於社會上出現「對等貿易協定沒有用」等疑美論，事實上ART協定不僅明文保障不疊加MFN（15%上限），還取得1,811項工業產品豁免，使輸美工業項目平均稅率狂降至12.32%。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:53:39.158143+08:00","guessed":true,"end":"2026-03-03T16:53:47.729571+08:00","text":"為破除不實疑慮，建請行政院具體說明為何台灣需儘速通過ART審查。","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:53:48.029571+08:00","guessed":true,"end":"2026-03-03T16:54:11.172429+08:00","text":"此外，若我國主動加速通過ART審查，向國際證明台灣完全有能力、也有意願承擔高標準的國際經貿與安全規範，此舉對我國未來申請加入CPTPP或其他雙邊協定，是否具備加分的示範效應？","quality":0},{"speaker":"委員王定宇書面質詢","start":"2026-03-03T16:54:11.472429+08:00","guessed":true,"end":"2026-03-03T16:54:14.901000+08:00","text":"建請行政院向國人清楚說明。","quality":0},{"speaker":"主席","start":"2026-03-03T16:54:15.201000+08:00","guessed":true,"end":"2026-03-03T16:54:21.772429+08:00","text":"接下來登記第18號王鴻薇委員請質詢，邱志偉委員請準備。","quality":0}]}},"supported_relations":[],"relations":[]}